SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) Stock Earnings Estimates

FRA:PSH0 • CA81752F1062

0.0915 EUR
+0 (+0.55%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PSH0.DE revenue by date.PSH0.DE revenue by date.
N/AN/AN/A
26,113.18%		N/A
445.06%		N/A
-58.12%		N/A
140.87%		N/A
68.95%		N/A
35.68%		N/A
22.11%
EBITDA
YoY % growth
PSH0.DE ebitda by date.PSH0.DE ebitda by date.
N/A-2.494M
-17.59%		-2.604M
-4.39%		-3.642M
-39.88%		-3.947M
-8.37%		-5.035M
-27.57%		-6.669M
-32.47%		-24.314M
-264.56%		-40.056M
-64.75%		-31.123M
22.30%		-14.68M
52.83%		N/A
-84.43%		N/A
236.68%		N/A
523.42%		N/A
-87.31%		N/A
352.79%		N/A
85.46%		N/A
56.69%		N/A
35.36%
EBIT
YoY % growth
PSH0.DE ebit by date.PSH0.DE ebit by date.
N/A-2.502M
4.74%		-2.643M
-5.67%		-3.706M
-40.21%		-4.008M
-8.14%		-5.26M
-31.23%		-6.937M
-31.88%		-24.754M
-256.86%		-40.502M
-63.62%		-31.664M
21.82%		-15.023M
52.55%		N/A
-191.78%		N/A
286.41%		N/A
470.33%		N/AN/AN/AN/AN/A
Operating Margin
PSH0.DE operating margin by date.PSH0.DE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
PSH0.DE eps by date.PSH0.DE eps by date.
N/AN/AN/AN/AN/AN/A
50.00%		N/A
-50.00%		-0.09
-494.06%		-0.13
-44.44%		-0.09
30.77%		N/A
4.61%		N/A
35.29%		N/A
18.18%		N/A
500.00%		N/A
-35.00%		N/A
170.85%		N/A
50.74%		N/A
32.66%		N/A
22.31%

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26
EPS
Q2Q % growth		-0.01
66.67%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth		 -0.01 -0.020.0150.50%
Q3 2025
Q2Q % growth		 -0.01
50.00%		-0.010.000.99%
Q2 2025
Q2Q % growth		 -0.01
66.67%		-0.020.0150.50%
Q1 2025
Q2Q % growth
-1.00%		-0.03%
Q4 2024
Q2Q % growth		 -0.01
75.00%		-0.030.0260.40%
Q3 2024
Q2Q % growth		 -0.02
33.33%		-0.030.0133.99%
Q2 2024
Q2Q % growth		 -0.03 -0.030.00-11.37%
Q1 2024
Q2Q % growth		 -0.03 -0.030.000.99%
Q4 2023
Q2Q % growth		 -0.04
-33.33%		-0.03-0.01-58.42%
Q3 2023
Q2Q % growth		 -0.03
-50.00%		-0.030.00-18.81%
Q2 2023
Q2Q % growth		 -0.03
-50.00%		-0.02-0.01-48.51%
Q1 2023
Q2Q % growth		 -0.03
-50.00%		-0.02-0.01-48.51%
Q4 2022
Q2Q % growth		 -0.03
-200.00%		-0.02-0.01-32.01%
Q3 2022
Q2Q % growth		 -0.02 -0.020.000.99%
Q2 2022
Q2Q % growth		 -0.02 -0.01-0.01-98.02%
Q1 2022
Q2Q % growth		 -0.02 -0.01-0.01-98.02%
Q4 2021
Q2Q % growth		 -0.01 -0.010.000.99%
PSH0.DE Yearly EPS VS EstimatesPSH0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 0.4 0.6
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
PSH0.DE Yearly Revenue VS EstimatesPSH0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 28.26% 28.26%
RevenueN/A N/A 0% 0%